On Monday, September 21, 2026, Dimed (PNVL3) approved, in an extraordinary meeting of the board of directors, the allocation of interest on equity (JCP, juros sobre capital próprio) in the total amount of R$ 18,000,000, corresponding to R$ 0.12061648048 per common share. The net amount per share, after withholding Income Tax at source, will be R$ 0.09950859640, except for corporate shareholders proven to be exempt, who will receive the full gross amount.
The JCP now approved will be credited against the annual dividend, will not be adjusted for inflation, and is subject to approval by the Annual General Meeting to be held in 2027. Payment will be made in three gross installments of R$ 0.04020549349 per share, with expected payment dates of March 31, 2028, April 28, 2028, and May 31, 2028.
Shareholders of Dimed (PNVL3) holding shares on September 24, 2026, will be entitled to the interest on equity. Payment will be subject to withholding Income Tax at source, in accordance with current legislation, and there will be no inflation adjustment or additional interest.
